Multiple daily injections (MDI): what they are, how they work, and what to expect
Multiple daily injections (MDI) is an insulin therapy approach that uses two types of insulin to manage glucose throughout the day: a long-acting basal insulin that provides steady background coverage, and a rapid-acting insulin taken before meals and to correct high glucose. For most people, MDI means several injections per day. It's one of the most widely used insulin regimens for people with type 1 diabetes and is also used in type 2 diabetes when insulin is needed throughout the day.
What are multiple daily injections?
Unlike an insulin pump or automated insulin delivery system, MDI is entirely self-administered. You manage insulin delivery yourself by calculating doses, deciding when insulin is needed, and administering injections with an insulin pen or syringe based on guidance by your healthcare provider. Every basal dose and every bolus is a decision you make. Together, they're designed to more closely mirror the way a healthy pancreas releases insulin: steadily in the background, and in response to meals.
MDI is a standard basal-bolus approach in clinical guidelines for people with type 1 diabetes, and it's also used in type 2 diabetes when a single basal dose isn't enough to cover daily insulin needs.¹
The two types of insulin used in MDI
MDI relies on two kinds of insulin working together:
- Long-acting (basal) insulin is injected once or twice a day. It releases slowly over 12 to 24 hours or more, providing a steady background level of insulin between meals and overnight. Basal insulin handles the glucose your liver produces when you're not eating.
- Rapid-acting (bolus) insulin is injected before meals. It works more quickly to match the glucose rise from carbs you eat. It can also be given as a correction dose when your glucose runs higher than your target.
This two-insulin approach is designed to give more flexibility and more physiologically accurate coverage than older fixed-dose regimens.
How many injections a day does MDI involve?
For most people, MDI means several injections per day; long-acting insulin usually taken at nighttime, and rapid acting insulin at mealtimes and any correction doses needed throughout the day. Your healthcare team will help determine how often and when to take each type of insulin. In addition to injections, people on MDI either use a CGM or they may check their glucose several times a day using a blood glucose meter to guide their dosing decisions. The exact number of injections varies by person and care plan, and your healthcare provider will work with you to determine what's right for your situation.
The benefits of MDI therapy
MDI is a widely used approach to insulin therapy that allows people to adjust insulin doses for meals, glucose levels, and daily activities as part of their diabetes management plan. Here's what makes it work well for so many people.
No wearable device required
MDI doesn't require wearing a device to dose insulin. For people who prefer not to have a device on their body (whether for personal comfort, work environment, or lifestyle), that can be an advantage.
Widely available and familiar to most endocrinologists
MDI uses insulin products and delivery tools (pens, cartridges, and syringes) that are familiar to nearly every diabetes care team in nearly any clinical setting. If you're newly diagnosed, your healthcare team may offer MDI as the first approach.
Ability to make correction doses with rapid-acting insulin
With MDI, you can take an additional dose of rapid-acting insulin any time your glucose runs higher than your target. That flexibility to correct on demand is a meaningful step up from older insulin regimens that offer less flexibility between meals.
The limitations of MDI
MDI works well for many people and at the same time asks a lot of you every single day. Below are limitations that people who have been on MDI for months or years can often feel accumulate over time.
Needle fatigue and injection frequency
Multiple daily injections add up quickly. If someone takes four injections per day, that's about 120 injections in a month and more than 1,400 in a year. Even with modern ultra-fine pen needles, the physical and psychological weight of that repetition can build over time. Injection burden and needle fatigue are well-recognized challenges in long-term MDI management, and they're among the primary reasons people eventually explore alternatives.¹
The mental load of MDI
Managing MDI means making active dosing decisions at nearly every meal: estimating how many carbs you're eating, calculating the right bolus, timing the injection to align with how quickly a particular food will raise your glucose, and adjusting for exercise, stress, or illness. That cognitive overhead is part of every day, not just when something goes wrong. Research shows that more than half of adults with diabetes in the U.S. experience some form of diabetes burnout, and the daily demands of dosing decisions could be a meaningful contributor.²
Overnight control and long-acting insulin variability
One of MDI's structural limitations is overnight glucose control. A long-acting basal insulin is designed to provide steady background insulin coverage while you sleep, but the dose is set ahead of time and cannot automatically respond to changing glucose levels overnight. Insulin absorption can vary depending on factors such as the injection site.³ That variability could make it harder to reliably stay in your target glucose range from bedtime to morning without additional adjustments.
Who is MDI right for?
The right insulin regimen depends on where you are in your diabetes journey, what matters most to you in daily management, and how your glucose patterns look on your current approach.
Signs MDI is the right fit
MDI tends to work well if you:
- Prefer not to wear a device on your body
- Are newly diagnosed and still building confidence with insulin management
- Have glucose patterns that a basal/bolus regimen can cover consistently
- Are comfortable with decisions about dosing and timing that MDI requires.
Signs it's worth exploring MDI alternatives
MDI may start to feel limiting, and alternatives may be worth a conversation with your healthcare provider, if you:
- Find the daily mental load of meal planning and dose timing exhausting over time
- Struggle with overnight glucose patterns that's hard to manage with a fixed basal dose
- Notice needle fatigue building after months or years of multiple daily injections
- Want more schedule flexibility without as much real-time calculation
- Find that your current regimen isn't getting your glucose where you and your healthcare provider want it to be
MDI vs. insulin pump therapy: a practical comparison
If you're weighing MDI against insulin pump therapy, the comparison often comes down to a few practical questions: How much physical and mental overhead is manageable for you? How important is overnight control? And how do you feel about wearing a device?
The table below lays out how the two approaches compare across the dimensions that tend to matter most.
For a broader look at how these two approaches compare across more situations, the insulin pump vs. multiple daily injections overview covers additional ground.
| MDI | Insulin pump therapy (includes AID and non-automated insulin pumps) | |
| Physical delivery | Several injections per day | Continuous delivery; device site changes every few days |
| Basal insulin | One or two long-acting injections daily | Rapid-acting insulin delivered continuously at programmable rates; adjusted based on sensor values if on AID system |
| Overnight control | Fixed long-acting dose; hard to target specific overnight patterns | Adjustable overnight basal rates; automated systems respond to real-time glucose changes |
| Device requirement | No on-body device to deliver insulin | Worn continuously, whether it's tubeless patch/Pod pump or tubed insulin pump |
| Lifestyle flexibility | No device to wear for dosing insulin | No multiple daily injections; all insulin is delivered through the pump |
| Learning curve | Familiar to most care teams; may be learning curve for patients | Initial training with a healthcare provider required; most people adapt within a few weeks |
The day-to-day difference between MDI and insulin pumps
In practice, one of the biggest day-to-day differences between MDI and insulin pump therapy is how insulin delivery is managed. With MDI, you typically take long-acting insulin once or twice a day and calculate mealtime and correction doses as needed. Depending on the pump system, insulin delivery can be adjusted throughout the day, and automated insulin delivery (AID) systems can automatically respond to glucose changes. For many people, this can reduce some of the day-to-day decision-making and manual adjustments involved in managing diabetes. The full range of insulin pump benefits goes beyond daily convenience and is worth discussing with your healthcare provider.
For people who use an automated insulin delivery (AID) system, a pump works together with a continuous glucose sensor and a dosing algorithm to automatically adjust insulin delivery. The system responds to glucose changes between meals and overnight without manual input from you.
What makes Omnipod® different from tubed pumps
Some people hesitate to try insulin pump therapy because of concerns about the physical aspects of wearing a device, including the tubing that connects traditional pumps to the infusion site on the body.4 If you've ever tried a conventional pump and found the tubing limiting or uncomfortable, that hesitation makes sense.
Rather than connecting to a reservoir through tubing, the Omnipod® 5 Automated Insulin Delivery System involves a small, wearable Pod that attaches directly to your skin and delivers insulin wirelessly. It pairs with compatible sensors* to automatically adjust insulin delivery.
Ariana Frayer spent nearly 20 years managing type 1 diabetes with MDI. She had tried a conventional tubed pump as a teenager and disliked the feeling of being physically attached to a device. When she was ready to reconsider pump therapy years later, the tubeless design of Omnipod 5 made the decision clear. After several months on the system, she described experiencing less diabetes burnout and noted the system "takes up far less brain space" than she expected. Read her full story on the Omnipod PodderTalk® blog.
Related Articles
Other topics
References and Disclaimers
*For a list of compatible smartphone devices visit omnipod.com/compatibility.
1. Brixner D, Edelman SV, Sieradzan R, Gavin JR III. Diabetes Therapy (2024). Narrative review of clinical and economic impacts of suboptimal glycemic control in adults with type 2 diabetes on basal-bolus insulin (MDI), and barriers to optimal MDI utilization, including injection pain, needle aversion, supply management demands, and social stigma as recognized drivers of suboptimal dosing. Diabetes Ther 15(7):1525-1534. DOI: 10.1007/s13300-024-01598-3.
2. Alexander DS, Saelee R, Rodriguez B, Koyama AK, Cheng YJ, Tang S, Rutkowski RE, McKeever Bullard K. Preventing Chronic Disease (2025). Cross-sectional study of 2021 National Health Interview Survey data among U.S. adults with diagnosed diabetes examining prevalence of diabetes distress. Adjusted prevalence of moderate and severe diabetes distress: 24.3% (95% CI, 22.5%–26.1%) and 6.6% (95% CI, 5.6%–7.8%), respectively; overall, more than half of U.S. adults with diabetes experienced diabetes distress. PMC11870017.
3. American Diabetes Association Professional Practice Committee for Diabetes. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026. Diabetes Care 2026;49(Suppl. 1):S183-S215.
4. Pauley ME, Berget C, Messer L, Forlenza G. Barriers to Uptake of Insulin Technologies and Novel Solutions. Medical Devices: Evidence and Research 2021;Volume 14:339-354. doi:10.2147/mder.s312858
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod® 5 System is intended for single patient, home use and requires a prescription. The Omnipod® 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Kirsty®, and Admelog®.
The Omnipod® 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod® 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The Omnipod 5 ACE Pump is intended for single patient, home use and requires a prescription.
The Omnipod 5 algorithm is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The Omnipod 5 algorithm is intended for the management of type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 algorithm is intended for single patient use and requires a prescription.
The Omnipod® 5 SmartBolus Calculator is software intended for the management of diabetes in persons aged 2 and older requiring rapid-acting U-100 insulin. The SmartBolus Calculator calculates a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.
Warning: The Omnipod 5 algorithm should NOT be used by anyone under the age of 2 years old. The Omnipod 5 algorithm should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod® 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod® 5 System according to instructions, are taking hydroxyurea and using a Dexcom Sensor as it could lead to falsely elevated sensor glucose values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod® 5 System, including alerts, alarms, and reminders. The Pod must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment, and the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.